Xin Zhou

6.1k total citations
165 papers, 4.6k citations indexed

About

Xin Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xin Zhou has authored 165 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 79 papers in Cancer Research and 47 papers in Oncology. Recurrent topics in Xin Zhou's work include MicroRNA in disease regulation (59 papers), Cancer-related molecular mechanisms research (40 papers) and Circular RNAs in diseases (34 papers). Xin Zhou is often cited by papers focused on MicroRNA in disease regulation (59 papers), Cancer-related molecular mechanisms research (40 papers) and Circular RNAs in diseases (34 papers). Xin Zhou collaborates with scholars based in China, United States and Hong Kong. Xin Zhou's co-authors include Wei Zhu, Zebo Huang, Tongshan Wang, Ping Liu, Huo Zhang, Wen‐Fang Cheng, Yiping Du, Tianzhu Qiu, Danxia Zhu and Xia Shan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xin Zhou

153 papers receiving 4.6k citations

Peers

Xin Zhou
Hushan Yang United States
Junchao Cai China
David John Germany
Russell G. Postier United States
Germana Castelli Italy
Matthias S. Matter Switzerland
Lin Xia China
Hao Xu China
Jie Hu China
Ilona Kovalszky Hungary
Hushan Yang United States
Xin Zhou
Citations per year, relative to Xin Zhou Xin Zhou (= 1×) peers Hushan Yang

Countries citing papers authored by Xin Zhou

Since Specialization
Citations

This map shows the geographic impact of Xin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Zhou more than expected).

Fields of papers citing papers by Xin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Zhou. The network helps show where Xin Zhou may publish in the future.

Co-authorship network of co-authors of Xin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Zhou. A scholar is included among the top collaborators of Xin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Zhou. Xin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Yu, Bin Liang, Wenqiang Song, et al.. (2025). Recovery of gold and iron oxide from pyrite cinder using reduction roasting, grinding, thiosulfate leaching in the presence of additives and magnetic separation. Hydrometallurgy. 233. 106453–106453. 2 indexed citations
2.
Zhang, Qi, Zhenzhen Han, Jiahui Liu, et al.. (2025). Hypoxia facilitates stemness of colon cancer cells via histone lactylation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(8). 167993–167993. 1 indexed citations
3.
Zhao, Hongfei, Zhuoya Zhang, Xin Zhou, et al.. (2025). Quantitative reconstruction of soil erosion process in a crater lake catchment during the Holocene, Southwest China. CATENA. 250. 108758–108758.
4.
Jin, Song, Junling Zhuang, Xin Zhou, et al.. (2024). Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study. Blood. 144(Supplement 1). 6970–6970.
5.
Hua, Rui, Min Li, Qiang Lin, et al.. (2024). Platelet membrane coated r-SAK to improve thrombolytic efficacy by targeting thrombus. European Heart Journal. 45(Supplement_1). 1 indexed citations
6.
7.
8.
Wu, Jing, et al.. (2023). Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer. Journal of Oncology. 2023. 1–10. 5 indexed citations
9.
10.
Liao, Xiwen, Xin Zhou, Chuangye Han, et al.. (2023). PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine. Volume 16. 337–355. 8 indexed citations
11.
Zhang, Lan, Qing Zhang, Zebo Huang, et al.. (2022). Integrated Analyses of m6A Regulator‐Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma. BioMed Research International. 2022(1). 2053719–2053719. 2 indexed citations
12.
13.
14.
15.
Zeng, Ailiang, Wei Yan, Zheng Wang, et al.. (2017). Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene. 36(38). 5369–5381. 100 indexed citations
16.
Huang, Zebo, Danxia Zhu, Lirong Wu, et al.. (2016). Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(2). 188–196. 114 indexed citations
17.
Zhu, Mingxia, Xin Zhou, Yiping Du, et al.. (2016). miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. Molecular Medicine Reports. 14(2). 1742–1750. 57 indexed citations
18.
Xu, Lei, Xin Zhou, Feng Jiang, Lin Xu, & Rong Yin. (2013). STK15 rs2273535 polymorphism and cancer risk: A meta-analysis of 74,896 subjects. Cancer Epidemiology. 38(2). 111–117. 10 indexed citations
19.
Xu, Lei, Xin Zhou, Feng Jiang, et al.. (2013). FASL rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects. PLoS ONE. 8(9). e74543–e74543. 7 indexed citations
20.
Zhou, Xin, et al.. (2012). Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.. PubMed. 18(25). 3303–9. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hushan Yang Breakdown of academic impact, for papers by Junchao Cai Breakdown of academic impact, for papers by David John Breakdown of academic impact, for papers by Russell G. Postier Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Matthias S. Matter Breakdown of academic impact, for papers by Lin Xia Breakdown of academic impact, for papers by Hao Xu Breakdown of academic impact, for papers by Jie Hu Breakdown of academic impact, for papers by Ilona Kovalszky
Rankless by CCL
2026